OMACOR
25-12-59. (R&D: RHM MED 0836)
Approved small_molecule completed
Quick answer
OMACOR for Non-Alcoholic Fatty Liver Disease is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Non-Alcoholic Fatty Liver Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed